Literature DB >> 30922778

MEF2C-related epilepsy: Delineating the phenotypic spectrum from a novel mutation and literature review.

Felippe Borlot1, Robyn Whitney2, Ronald D Cohn3, Shelly K Weiss1.   

Abstract

PURPOSE: MEF2C-related epilepsy has been poorly described in the literature, despite a consistent MEF2C haploinsufficiency phenotype characterized by severe language impairment and motor delay (MIM# 613443). We aimed to delineate the spectrum of electroclinical manifestations of MEF2C-related epilepsy from an illustrative case and literature review.
METHODS: A retrospective chart review of our case was performed followed by a literature review on PubMed and OMIM. Publications including patients with MEF2C pathogenic, likely pathogenic variants, or microdeletions without involvement of other genes were selected.
RESULTS: The index case is a 2-year-old male with global developmental delay who presented at 7 months with atypical febrile seizures, generalized myoclonias, and focal impaired awareness seizures. Neuroimaging studies were unremarkable and electroencephalograms showed high voltage 200-400uV, 2-2.5 Hz generalized spike-and-waves and polyspikes with alternating frontal predominance, and multifocal spike-and-slow waves. Whole exome sequencing showed an unreported de novo likely pathogenic variant in the MEF2C gene c.236 G > C (p.Arg79Pro). Data from ten additional publications including 22 patients were gathered. From the 23 patients in total, 19 (82%) had seizures. Febrile seizures were most common, but myoclonic, focal-onset and generalized seizures were also reported. Electroencephalogram findings were described in eleven, and nine (82%) showed epileptiform abnormalities.
CONCLUSION: MEF2C-related epilepsy may be described as a spectrum of manifestations including febrile seizures, myoclonia, and focal-onset or generalized seizures. Electroencephalogram is consistently abnormal, showing findings such as background slowing, multifocal and generalized epileptiform discharges and polyspikes. It remains unclear whether most patients are responsive or refractory to treatment with anti-epileptic medications. Crown
Copyright © 2019. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  EEG; Electroclinical manifestations; Epilepsy; MEF2C; Myoclonia

Mesh:

Substances:

Year:  2019        PMID: 30922778     DOI: 10.1016/j.seizure.2019.03.015

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  7 in total

1.  LncRNA UCA1 Suppresses the Inflammation Via Modulating miR-203-Mediated Regulation of MEF2C/NF-κB Signaling Pathway in Epilepsy.

Authors:  Qian Yu; Meng-Wen Zhao; Pu Yang
Journal:  Neurochem Res       Date:  2020-02-13       Impact factor: 3.996

2.  Identification of a novel mutation in MEF2C gene in an atypical patient with frontotemporal lobar degeneration.

Authors:  Andreia Adrião; Isabel Santana; Carolina Ribeiro; M Leonor Cancela; Natércia Conceição; Manuela Grazina
Journal:  Neurol Sci       Date:  2021-05-17       Impact factor: 3.307

3.  Genotypes and Phenotypes of MEF2C Haploinsufficiency Syndrome: New Cases and Novel Point Mutations.

Authors:  Lin Wan; Xinting Liu; Linyan Hu; Huimin Chen; Yulin Sun; Zhichao Li; Zhenfang Wang; Zhi Lin; Liping Zou; Guang Yang
Journal:  Front Pediatr       Date:  2021-05-13       Impact factor: 3.418

4.  Phenotypic analysis of catastrophic childhood epilepsy genes.

Authors:  Aliesha Griffin; Colleen Carpenter; Jing Liu; Rosalia Paterno; Brian Grone; Kyla Hamling; Maia Moog; Matthew T Dinday; Francisco Figueroa; Mana Anvar; Chinwendu Ononuju; Tony Qu; Scott C Baraban
Journal:  Commun Biol       Date:  2021-06-03

Review 5.  Progress on the roles of MEF2C in neuropsychiatric diseases.

Authors:  Zhikun Zhang; Yongxiang Zhao
Journal:  Mol Brain       Date:  2022-01-06       Impact factor: 4.041

6.  The Cell Adhesion Molecule L1 Interacts with Methyl CpG Binding Protein 2 via Its Intracellular Domain.

Authors:  Gabriele Loers; Ralf Kleene; Maria Girbes Minguez; Melitta Schachner
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

7.  Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress.

Authors:  Timea Aczél; Bettina Benczik; József Kun; Zsuzsanna Helyes; Bence Ágg; Tamás Körtési; Péter Urbán; Witold Bauer; Attila Gyenesei; Bernadett Tuka; János Tajti; Péter Ferdinandy; László Vécsei; Kata Bölcskei
Journal:  J Headache Pain       Date:  2022-09-02       Impact factor: 8.588

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.